FDA Approved Medical Products for:

Carcinoid tumor

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name everolimus
Trade Name
(Manufacturer Name)
Afinitor
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adult patients with progressive, well differentiated, nonfunctional,neuroendocrine tumors(NET) of gastrointestinal (GI) or lung origin, (excluding pancreatic) with unresectable, locally advanced or metastatic disease.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Gallium [Ga-68]
Trade Name
(Manufacturer Name)
Netspot
(Advanced Accelerator Applications, USA)
Indication
The FDA has approved this product to be used in this manner.
For use after radiolabeling with Ga 68, with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.
More Information about this product Drug Information Portal

Generic Name Octreotide
Trade Name
(Manufacturer Name)
Sandostatin LAR
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly.
More Information about this product Drug Information Portal
Medline Plus Health Information